Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Phosphomannose isomerase (PMI) deficiency is the cause of a new type of carbohydrate-deficient glycoprotein syndrome (CDGS). The disorder is caused by mutations in the PMI1 gene. The clinical phenotype is characterized by protein-losing enteropathy, while neurological manifestations prevailing in other types of CDGS are absent. Using standard diagnostic procedures, the disorder is indistinguishable from CDGS type Ia (phosphomannomutase deficiency). Daily oral mannose administration is a successful therapy for this new type of CDG syndrome classified as CDGS type Ib.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphomannomutase deficiency is a cause of carbohydrate‐deficient glycoprotein syndrome type I
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)01357-1 · Cited by 359 · cited 6×
“ing to a procedure by van Schaftingen and Jaeken (6).”
BackgroundMethodInfluentialJaeken, J., Vanderschueren-Lodeweyckx, M., Casaer, P., Snoeck, L., Corbeel, L., Eggermont, E., & Eeckels, R. (1980) · Pediatric Research · doi:10.1203/00006450-198002000-00117 · Cited by 287 · cited 1×
“(1) Hexokinase; (2) glucose 6-phosphate dehydrogenase; (3) phosphoglucose isomerase; (4) phosphomannose isomerase; (5) phosphomannomutase; (6) GDPmannose synthase.”
Panneerselvam, K., & Freeze, H. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118570 · Cited by 146 · cited 1×
“Based on studies showing that mannose could correct abnormal glycosylation in CDGS type Ia fibroblasts (15), mannose therapy was initiated and followed up for 11 mo.”
BackgroundSelf-citationThe X-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 Å resolution
Cleasby, A., Wonacott, A. J., Skarzynski, T. J., Hubbard, R. E., Davies, G. J., Proudfoot, A. E. I., Bernard, A. R., Payton, M. A., & Wells, T. N. C. (1996) · Nature Structural Biology · doi:10.1038/nsb0596-470 · Cited by 115
Alton, G., Kjærgaard, S., Etchison, J. R., Skovby, F., & Freeze, H. H. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1997.2574 · Cited by 111 · cited 1×
“In accordance with previous human ingestion studies (19), mannose was given orally in an initial dose of 100 mg/kg body wt three times a day.”
Self-citationCarbohydrate-Deficient Glycoprotein Syndrome - A Fourth Subtype
Stibler, H., Stephani, U., & Kutsch, U. (1995) · Neuropediatrics · doi:10.1055/s-2007-979762 · Cited by 92 · cited 1×
“(1) Hexokinase; (2) glucose 6-phosphate dehydrogenase; (3) phosphoglucose isomerase; (4) phosphomannose isomerase; (5) phosphomannomutase; (6) GDPmannose synthase.”
Purification cDNA cloning and heterologous expression of human phosphomannose isomerase
PROUDFOOT, A. E. I., TURCATTI, G., WELLS, T. N. C., PAYTON, M. A., & SMITH, D. J. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19954.x · Cited by 86 · cited 3×
“The sequence of the human PMI cDNA (10) was used to design primers for PCR amplification.”
BackgroundMethodInfluentialCarbohydrate-Deficient Glycoprotein (CDG) Syndrome - A New Variant, Type III
Stibler, H., Westerberg, B., Hanefeld, F. A., & Hagberg, B. (1993) · Neuropediatrics · doi:10.1055/s-2008-1071513 · Cited by 71 · cited 1×
“(1) Hexokinase; (2) glucose 6-phosphate dehydrogenase; (3) phosphoglucose isomerase; (4) phosphomannose isomerase; (5) phosphomannomutase; (6) GDPmannose synthase.”
Human Fibroblasts Prefer Mannose over Glucose as a Source of Mannose for N-Glycosylation
Panneerselvam, K., Etchison, J. R., & Freeze, H. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23123 · Cited by 70
Self-citationA novel Saccharomyces cerevisiae secretory mutant possesses a thermolabile phosphomannose isomerase
Payton, M. A., Rheinnecker, M., Klig, L. S., Detiani, M., & Bowden, E. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.6.2006-2010.1991 · Cited by 70 · cited 1×
“Phenotypic correction of the PMI deficiency in yeast was achieved by supplying 5 mM mannose together with glucose (20).”
Method
Cited by
Items 401–427 of 427
Cummings, R. D., & Canfield, W. M. (2002) · Wiley eBooks · doi:10.1002/047120918x.emb0616
Other forms of congenital disorders of glycosylation
Nyhan, W., Hoffmann, G. F., Barshop, B., & Al-Aqeel, A. (2011) · CRC Press eBooks · doi:10.1201/b13564-119
Trastornos congénitos de la glucosilación de las glucoproteínas séricas
de Lonlay, P., & Séta, N. (2020) · EMC - Pediatría · doi:10.1016/s1245-1789(20)43426-2
Individual Treatment Trial of PIGV-Associated Mabry Syndrome with D-Mannose in a Young Child
Agnes, S. M., Arlt, A., Peter, K., Baumkötter, J., & Mall, V. (2023) · Journal of Genetic Medicine and Gene Therapy · doi:10.29328/journal.jgmgt.1001008
Stormon, M., Mitchell, J. D., Smoleniec, J., Tobias, V., & Day, A. S. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2002.tb07931.x
Additional file 3 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054321
Additional file 5 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054330
Additional file 2 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054318
Witters, P., Edmondson, A. C., Lam, C. T., Johnsen, C., Patterson, M. C., Raymond, K., He, M., Freeze, H. H., & Morava, É. (2021) · Figshare · doi:10.6084/m9.figshare.14121539
Self-citationAdditional file 1 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054312
Additional file 4 of Congenital disorders of glycosylation: narration of a story through its patents
Monticelli, M., D’Onofrio, T., Jaeken, J., Morava, É., Andreotti, G., & Cubellis, M. V. (2023) · Figshare · doi:10.6084/m9.figshare.24054324
Congenital disorders of N-linked Glycosylation
Patterson, M. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00009-1
Enteropathies Associated with Chronic Diarrhea and Malabsorption of Childhood
Russo, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-62589-3_4
Mannose phosphate isomerase-congenital disorder of glycosylation leads to asymptomatic hypoglycemia
Luo, C., Peng, D., Li, Y., Liu, S., Wu, Q., Xu, X., & Wen, J. (2024) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2024.101162
Patterson, M. C., Ng, B. G., & Eklund, E. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00062-7
Biliary Atresia and Neonatal Disorders of the Bile Ducts
Samyn, M., Hadžić, N., & Mieli‐Vergani, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11760-2.00070-7
Montanari, C., Tagi, V. M., Tosi, M., Stucchi, E., Pisano, E. M., Raso, I., Fini, G., Fiori, L., Mannarino, S., Zuccotti, G., et al. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1648010
Rindermann, J. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1655
Neurometabolische und neurodegenerative Krankheiten
Gärtner, J., Körner, C., Kohlschütter, A., Muschol, N., Schneider, S. A., Spiekerkoetter, U., Steinfeld, R., Thiel, C., & Wilichowski, E. (2014) · Elsevier eBooks · doi:10.1016/b978-3-437-23076-9.00005-x
Self-citationAdditional file 1 of Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG)
Taday, R., Grüneberg, M., Chesne, I. D., Reunert, J., & Marquardt, T. (2020) · Figshare · doi:10.6084/m9.figshare.12992107
Self-citationMannose metabolic pathway senses glucose supply and regulates cell fate decisions
Wang, Z., Miyamoto, Y., Suzuki, T., Tanaka, M., Mizote, Y., Dohmae, N., Tahara, H., Taniguchi, N., & Harada, Y. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111213 · Cited by 1
Biosynthèse et dégradation des N-glycoprotéines : un métabolisme intimement lié à la Man2C1
Bernon, C. (2010) · theses.fr (ABES) · doi:10.70675/d665d42ez6918z4d0dz85c9z3a4636198d9c
Luo, J., Shao, W., Liu, S., Liang, Z., Dong, X., Xu, S., Hou, H., Zuo, D., & Luo, J. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103589
“Mannose is detectable in human serum [10] and supplementation of mannose at supraphysiological concentrations has been shown as a safe and effective therapy for patients suffering from carbohydrate-deficient glycoprotein syndrome [11,12] or recurring urinary tract infections [13].”
Sonstige angeborene Stoffwechselsstöru ngen
Muntau, A. C. (2004) · Springer eBooks · doi:10.1007/978-3-662-10471-2_18
Neurometabolische und neurodegenerative Erkrankungen
Hanefeld, F. A., Kohlschütter, A., Brockmann, K., Henneke, M., Assmann, B. E., Plecko, B., Wolf, N. I., & Korinthenberg, R. (2014) · Springer eBooks · doi:10.1007/978-3-642-41866-2_211
Genetic and biochemical insights into muscular dystrophy-dystroglycanopathy pathomechanisms
Riemersma, M. (2015) · Radboud Repository (Radboud University)
Metadata
- Authors
- Niehues, R., Hasilik, M., Alton, G., Körner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., von Figura, K., Freeze, H. H., Harms, H. K., & Marquardt, T.
- Affiliations
- University Hospital Münster (DE)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of Göttingen (DE)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-04-01
- Volume
- 101
- Issue
- 7
- Pages
- 1414-1420
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508719
- OpenAlex
- W1970122244
- Cited by
- 422
- References
- 20
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 13 · 2023: 11 · 2022: 8 · 2021: 14 · 2020: 16 · 2019: 7 · 2018: 12 · 2017: 12 · 2016: 4 · 2015: 13 · 2014: 18 · 2013: 7 · 2012: 14
- FWCI
- 22.32
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01gm049096-04)
- National Institute of General Medical Sciences (R01 GM49096)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- protein-losing enteropathy, phosphomannomutase deficiency
- MeSH terms
- Cells, Cultured, Glycoproteins, Glycosylation, Humans, Infant, Male, Mannose, Mannose-6-Phosphate Isomerase, Mutation, Protein Processing, Post-Translational, Protein-Losing Enteropathies, Syndrome, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.